IP Verse

Tablet Including 7-[4-(4-Benzo[Beta]Thiophen-4-Yl-Piperazin-1-Yl) Butoxy]-1H-Quinolin-2-One Or Salt Thereof - EP2767285B2

PatentPatent Analysis

EP2767285

OTSUKA PHARMACEUTICAL
Application Number
EP12840025A
Filing Date
Oct 12, 2012
Status
Patent Maintained As Amended
Jan 17, 2025
Grant Date
Feb 19, 2025
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4125903B1
EP4069254B1
EP2841431B2

Bibliography

The patent EP2767285B2 was granted to Otsuka Pharmaceutical on Feb 19, 2025 following the initial filing on Oct 12, 2012 under the application number EP12840025A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

TEVA PHARMACEUTICALSAug 12, 2020ADMISSIBLE
MAIWALDAug 11, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents